| 江蘇荃信生物醫藥股份有限公司-H股, 02509.HK - 盈利摘要 |
2022-12 |
2021-12 |
2020-12 |
| 盈利(百萬) |
-298 |
-411 |
0 |
| 盈利增長(%) |
27.45 |
0.0 |
0.0 |
| 每股盈利(港元) |
-1.68 |
-2.57 |
0.0 |
| 每股盈利增長(%) |
34.63 |
0.0 |
0.0 |
| 每股派息(港元) |
0.0 |
0.0 |
0.0 |
| 市盈率(倍) |
0.0 |
0.0 |
0.0 |
| 周息率(%) |
0.0 |
0.0 |
0.0 |
| 派息比率(%) |
0.0 |
0.0 |
0.0 |
| 每股賬面資產淨值 |
2.8897 |
0.0 |
0.0 |
| 報告貨幣 |
| 基準貨幣 |
| 兌換比率 |
1.0 |
1.0 |
1.0 |
說明：兌換比率資料來源於香港金融管理局《金融資料月報》
|
We've noticed you're using an ad blocker
We spend millions of dollars each year so you can access, for FREE, the highest quality real-time quotes and charts. This is made possible only thanks to the advertising on our site.
To continue using 88iv.com, please allow this domain on your ad blocker.
We are thanksful for your decisive action.
This notice will be shown again every hour.
Close This Window